Development and early implementation of an Accessible, Relational, Inclusive and Actionable approach to genetic counseling: The ARIA model.
Genetic counseling
Genetics education
Genomics
Health communication
Health literacy
Medically underserved
Journal
Patient education and counseling
ISSN: 1873-5134
Titre abrégé: Patient Educ Couns
Pays: Ireland
ID NLM: 8406280
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
received:
14
03
2020
revised:
07
12
2020
accepted:
21
12
2020
pubmed:
8
2
2021
medline:
22
5
2021
entrez:
7
2
2021
Statut:
ppublish
Résumé
To describe the training and early implementation of the ARIA model of genetic counseling (Accessible, Relational, Inclusive, Actionable). As part of the Cancer Health Assessments Reaching Many (CHARM) study, an interdisciplinary workgroup developed the ARIA curriculum and trained genetic counselors to return exome sequencing results using the ARIA model. The ARIA curriculum includes didactic elements, discussion, readings, role plays, and observations of usual care genetic counseling sessions. The ARIA model provides the skills and strategies needed for genetic counseling to be accessible to all patients, regardless of prior knowledge or literacy level; involves appropriate psychological and social counseling without overwhelming the patient with information; and leaves the patient with clear and actionable next steps. With sufficient training and practice, the ARIA model appears to be feasible, with promise for ensuring that genetic counselors' communication is accessible, relational, inclusive and actionable for the diverse patients participating in genomic medicine. ARIA offers a coherent set of principles and strategies for effective communication with patients of all literacy levels and outlines specific techniques to practice and incorporate these skills into routine practice. The ARIA model could be integrated into genetic counseling training programs and practice, making genetic counseling more accessible and meaningful for all patients.
Identifiants
pubmed: 33549385
pii: S0738-3991(20)30681-9
doi: 10.1016/j.pec.2020.12.017
pmc: PMC8881934
mid: NIHMS1657506
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Pagination
969-978Subventions
Organisme : NHGRI NIH HHS
ID : U01 HG007292
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG007307
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG007307
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG007292
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors report no declarations of interest.
Références
Eur J Med Genet. 2019 May;62(5):357-367
pubmed: 30553023
J Genet Couns. 2012 Apr;21(2):151-61
pubmed: 22134580
JAMA Intern Med. 2018 Jul 1;178(7):999
pubmed: 29971366
Am J Hum Genet. 2018 Apr 5;102(4):540-546
pubmed: 29526281
J Genet Couns. 2016 Oct;25(5):868-79
pubmed: 27333894
J Genet Couns. 2016 Jun;25(3):472-82
pubmed: 26455498
Annu Rev Genomics Hum Genet. 2013;14:491-513
pubmed: 24003856
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):38-45
pubmed: 29512933
Nat Rev Genet. 2018 Mar;19(3):175-185
pubmed: 29151588
J Genet Couns. 2014 Apr;23(2):239-53
pubmed: 24158360
J Genet Couns. 2017 Apr;26(2):334-336
pubmed: 27804046
Mol Genet Genomic Med. 2013 Nov;1(4):189-93
pubmed: 24498615
J Genet Couns. 2017 Oct;26(5):902-933
pubmed: 28255928
J Genet Couns. 2018 Feb;27(1):155-168
pubmed: 28791541
J Genet Couns. 2017 Oct;26(5):1090-1104
pubmed: 28289853
J Genet Couns. 2013 Apr;22(2):155-63
pubmed: 23188549
Health Commun. 2019 Nov;34(13):1608-1618
pubmed: 30230379
Genet Med. 2020 Jun;22(6):1094-1101
pubmed: 32089547
J Genet Couns. 2019 Dec;28(6):1166-1177
pubmed: 31549758
BMC Fam Pract. 2016 Jul 22;17:89
pubmed: 27445117
Genet Med. 2015 Oct;17(10):822-30
pubmed: 25590980
J Genet Couns. 1997 Sep;6(3):287-95
pubmed: 26142236
BMC Med Genomics. 2018 Feb 13;11(1):18
pubmed: 29433521
Arch Intern Med. 2003 Jan 13;163(1):83-90
pubmed: 12523921
Breast Cancer Res Treat. 2015 May;151(1):169-76
pubmed: 25868867
Health Aff (Millwood). 2016 Aug 1;35(8):1367-73
pubmed: 27503959
J Public Health Policy. 2007;28(1):71-93
pubmed: 17363939
Genet Med. 2019 Jan;21(1):181-184
pubmed: 29740170
Cancers (Basel). 2018 Nov 13;10(11):
pubmed: 30428547
Mol Genet Genomic Med. 2017 Jul 02;5(5):508-515
pubmed: 28944234
Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):24-37
pubmed: 29512888
J Genet Couns. 2014 Aug;23(4):445-51
pubmed: 24504939
Health Lit Res Pract. 2017 Oct 10;1(4):e173-e181
pubmed: 31294263
J Clin Oncol. 2017 Jul 1;35(19):2165-2172
pubmed: 28489507
J Genet Couns. 2006 Apr;15(2):77-83
pubmed: 16761103
Nature. 2016 Oct 12;538(7624):161-164
pubmed: 27734877
J Genet Couns. 2021 Feb;30(1):42-50
pubmed: 33278053
Genet Med. 2013 Aug;15(8):658-63
pubmed: 23448722
BMC Med Genomics. 2018 May 8;11(1):45
pubmed: 29739461
Am J Hum Genet. 2018 Sep 6;103(3):319-327
pubmed: 30193136
Gynecol Oncol. 2018 Apr;149(1):84-88
pubmed: 29605055
Expert Rev Mol Diagn. 2017 Jan;17(1):57-70
pubmed: 27910721
J Community Genet. 2018 Jul;9(3):263-276
pubmed: 29197036